A phosphonamide peptide, N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid, previously shown to block Clostridium histolyticum collagenases, was examined as a putative inhibitor of endopeptidase 24.16 and endopeptidase 24.15. Hydrolysis of two endopeptidase 24.16 substrates, i.e. 3-carboxy-7-methoxycoumarin (Mcc)-Pro-Leu-Gly-Pro-DLys-dinitrophenyl (Dnp) and neurotensin, were completely and dose-dependently inhibited by the phosphonamide inhibitor with KI values of 0.3 and 0.9 nm respectively. In addition, the phosphonamide peptide inhibited the hydrolysis of benzoyl (Bz)-Gly-Ala-Ala-Phe-(pAB) p-aminobenzoate and neurotensin by endopeptidase 24.15 with about a 10-fold lower potency (KI values of 5 and 7.5 nm respectively). The selectivity of this inhibitor towards several exo-and endopeptidases belonging to the zinc-containing metallopeptidase family established that a 1 ,tM concentration of this inhibitor was unable to affect leucine aminopeptidase, carboxypeptidase A, angiotensin-converting enzyme and endopeptidase 24.11. The present paper therefore reports on the first hydrophilic highly potent endopeptidase 24.16 inhibitor and describes the most potent inhibitory agent directed towards endopeptidase 24.15 developed to date. These tools should allow one to assess the contribution of endopeptidase 24.16 and endopeptidase 24.15 to the physiological inactivation of neurotensin as well as other neuropeptides.
INTRODUCTION
We previously isolated a novel endopeptidase from rat brain (Checler et al., 1986) and intestine on the basis of its ability to inactivate the tridecapeptide neurotensin. Interestingly, this peptidase [now called endopeptidase 3.4.24.16, neurotensin endopeptidase or neurolysin (Webb, 1984) ] was shown to be ubiquitously involved in the mechanisms of neurotensin inactivation in membrane and cell preparations that bear the specific receptors that mediate the neurotensinergic message . This feature, together with the observation that endopeptidase 24.16 was co-located with neurotensin receptors on a discrete population of primary cultured neurons of cerebral hemispheres from mice embryos (Chabry et al., 1990) , suggested the enzyme as a putative candidate for the physiological inactivation of neurotensin. However, such a hypothesis is not antagonistic to the possibility that endopeptidase 24.16 participates in the metabolism of other neuropeptides. In agreement with this fact was the observation that several peptides, including angiotensin I, substance P, bradykinin and dynorphin 1-8, behaved as substrates of endopeptidase 24.16 in vitro (Checler et al., 1986; Yoshikawa et al., 1988) .
Endopeptidase 24.16 was reported to belong to the metallopeptidase family with respect to its potent inhibition by several metal chelators such as o-phenanthroline and EDTA (Checler et al., 1986; Barelli et al., 1988) , and its sensitivity to various bivalent cations, including Zn2+, Cu2+ and Co2+ . The fact that Zn2+ seemed to be the most powerful agent capable of restoring the activity of the apoenzyme suggested that endopeptidase 24.16 could be a novel member of the growing family of the zinc-containing metallopeptidases. A crucial step in the development of specific inhibitors of such a class of proteolytic activities consists in the co-ordination of the zinc atom. This can be achieved by several metal co-ordinating groups that include carboxyalkyls, thiols, hydroxamates and phospho groups. Concerning the latter, it is well known that the natural phospho-group-containing substance phosphoramidon behaves as an excellent inhibitor of two metallopeptidases, namely thermolysin and endopeptidase 24-11 (Suda et al., 1973; Mumford et al., 1981) . More recently it was reported that synthetic substrate analogues in which the scissile bond was replace by a tetrahedral phosphonamide moiety could act as potent thermolysin and carboxypeptidase A inhibitors (Barlett & Marlowe, 1987; Hanson et al., 1989) , most likely by mimicking the transition state of the catalysis reaction. Indeed, the phosphonamide moiety is similar to the tetrahedral intermediate that arises from the addition of the zinc-water complex to the carbonyl side of the cleaved amide bond. Phosphonamide peptides were also successfully designed as potent inhibitors of bacterial collagenases from Clostridium histolyticum (Dive et al., 1990) . Interestingly, the structure of one of these inhibitors, N-(phenylethylphosphonyl)-Gly-L-Pro-Laminohexanoic acid (referred to hereafter as phosphodiepryl 03) resembled the Leu-Gly-Pro sequence feature of a fluorimetric substrate 3-carboxy-7-methoxycoumarin (Mcc)-Pro-Leu-GlyPro-DLys-dinitrophenyl (Dnp) that was recently designed as a probe to monitor Pz peptidase [endopeptidase 24.15; Thimet oligopeptidase ] and that was shown to undergo an identical proteolytic cleavage at the Leu-Gly bond by endopeptidase 24.16 (Dauch et al., 199 la (Strasbourg, France) . The phosphonamide inhibitor phosphodiepryl 03 was prepared as previously described (Dive et al., 1990 ).
H.p.l.c. and fluorimetric assay of Mcc-Pro-Leu-Gly-Pro-D-LysDnp hydrolysis by endopeptidase 24.16 Mcc-Pro-LeU-Gly-Pro-D-Lys-D1np (50 EM) was incubated for 1 h at 37°C with 10 ,ul of purified endopeptidase 24.16 (Checler et al., 1986 ) in a final volume of 100,ul of 50 mM-Tris/HCl, pH 7.5, in the absence (control) or in the presence of 10-2 Mprolylisoleucine or increasing concentrations of phosphodiepryl 03. Incubations were stopped and fluorimetrically recorded as previously described (Dauch et al., 1991a) or h.p.l.c.-analysed by means of a 42 min linear gradient of 0.1 % trifluoroacetic acid/0.05 % triethylamine in acetonitrile from 3: 1 (v/v) to 1 :4 (v/v) as previously described Checler, 1992) .
H.p.l.c. analysis of neurotensin and Bz-Gly-Ala-Ala-Phe-pAB hydrolysis Neurotensin (2 nmol) or Bz-Gly-Ala-Ala-Phe-pAB (5 nmol) were incubated for various times at 37°C with 10 ,ul of posthydroxyapatite fractions of endopeptidase 24.15 (neurotensin and Bz-Gly-Ala-Ala-Phe-pAB) or endopeptidase 24.16 (neurotensin) in the absence or in the presence of increasing concentrations of inhibitor. Incubations were acidified and reverse-phase-h.p.l. Endopeptidase 24.16 was purified as previously described (Checler et al., 1986) , and endopeptidase 24.15 was isolated as recently reported (Barelli et al., 1991; Dauch et al., 1991a) .
RESULTS
Effect of phosphodiepryl 03 on endopeptidase 24.16 We previously reported on the hydrolysis of the fluorimetric substrate Mcc-Pro-Leu-Gly-Pro-D-Lys-Dnp by purified endopeptidase 24.16 (sp. activity 215 nmol/h per mg of protein; Dauch et al., 1991a) . As expected, h.p.l.c. analysis indicated that a single proteolytic cleavage occurred at the Leu-Gly peptide bond (Fig. la) . The formation of these products was abolished by prior incubation of endopeptidase 24.16 with the dipeptide prolylisoleucine, which was previously shown to selectively block endopeptidase 24.16 ( Fig. lb) (Dauch et al., 1991b) . Mcc-ProLeu-Gly-Pro-D-Lys-Dnp hydrolysis by endopeptidase 24.16 could be inhibited in a dose-dependent manner and completely by phosphodiepryl 03, with a half-maximal effect obtained at a concentration of 1 nm (Fig. lc) .
The effect of the inhibitor was confirmed by monitoring the ability of endopeptidase 24.16 to cleave neurotensin. As previously reported, endopeptidase 24.16 hydrolysed neurotensin at the Pro"0-Tyr"' bond, yielding the biologically inert fragments neurotensin-(1-10)-peptide and neurotensin-(1 1-13)-peptide (Checler et al., 1986; Barelli et al., 1988) (Fig. 2a) . The total lack of neurotensin-(1-8)-peptide and neurotensin-(9-1 3)-peptide formation, together with the inability of endopeptidase 24.16 to cleave the endopeptidase 24.15 chromogenic substrate Bz-GlyAla-Ala-Phe-pAB, clearly indicated that endopeptidase 24.16 was not contaminated by endopeptidase 24.15, as previously discussed (Barelli et al., 1991) . Neurotensin hydrolysis appeared completely abolished by 1 /LM-phosphodiepryl 03 (Fig. 2a) , with an IC50 (concentration causing 50 % of maximal inhibition) of 10 nm (Fig. 2c) . Taking (Fig. 2b) the formation of equimolar amounts of neurotensin-(1-8)-peptide and neurotensin-(9-13)-peptide deriving from a single breakdown at the Arg8-Arg9 peptidyl bond of neurotensin that also appeared totally prevented by 1 4aM-CPP-Ala-Ala-Tyr-pAB (results not shown). Here again, a 1 ,uMconcentration of the phosphonamide inhibitor induced a complete inhibitory effect of endopeptidase 24.15 (Fig. 2b ) with a half-maximal effect occurring at about 100 nm (Fig. 2c) .
The endopeptidase 24.15 chromogenic substrate Bz-Gly-AlaAla-Phe-pAB underwent a single proteolytic cleavage by endopeptidase 24.15, leading to Bz-Gly and its complementary sequence Ala-Ala-Phe-pAB (Fig. 3a) . This cleavage appeared fully abolished by 1 /tM-N-(1R,1S)-carboxy-3-phenylpropyl-(CPP)-Ala-Ala-Tyr-pAB (results not shown), a compound that was described as a potent (KI -16 nM) inhibitor ofendopeptidase 24.15 (Orlowski et al., 1988) . Phosphodiepryl 03 at 1 /tM prevented the formation of the two degradation products (Fig. 3b) , with a half-maximal effect elicited at 5 nm (Fig. 3c) .
The KI values of phosphodiepryl 03 on the hydrolysis of BzGly-Ala-Ala-Phe-pAB and neurotensin derived from the above experiments appeared in close agreement (5-7.5 nM; Table 1 ).
Effect of phosphodiepryl 03 on other zinc-containing exo-and endo-metallopeptidases Leucine aminopeptidase, carboxypeptidase A, angiotensinconverting enzyme and endopeptidase 24.11 activities were h.p.l.c.-monitored by measuring the hydrolysis of leucyl 7-amido-4-methylcoumarylamide, Hippuryl-Phe, Hippuryl-HisLeu and neurotensin respectively as previously described (Dauch et al., 1991b) . The chromatograms showed that the various substrates were cleaved at the expected peptide sites (Checler, 1992) and were fully abolished by pretreatment with saturating concentrations of their specific inhibitors [bestatin (leucine aminopeptidase), arphamenine B (carboxypeptidase A), captopril (angiotensin-converting enzyme) and phosphoramidon (endopeptidase 24.11) (results not shown)], indicating that the observed hydrolyses were indeed due to the expected proteolytic activities and not attributable to contaminating peptidases present in the commercial batches. All these metallopeptidases remained totally insensitive to 1uM-phosphodiepryl 03 (results not shown).
DISCUSSION
The possibility of assessing the contribution of any peptidase in the inactivation of neuropeptides is dependent on the development of potent, selective and bioavailable inhibitors. This prompted us to search for inhibitory agents of endopeptidase 24.16. We recently demonstrated that several dipeptides mimicking the Pro-Tyr bond of neurotensin hydrolysed by endopeptidase 24.16 could be used as selective blockers of this enzyme (Dauch et al., 199 lb) . Among them, prolylisoleucine was shown to inhibit endopeptidase 24.16 with a KI value of 90,uM, whereas a 5 mm concentration of this agent had no effect on endopeptidases 24.11 and 24.15, proline endopeptidase, angiotensin-converting enzyme, leucine aminopeptidase, carboxypeptidases A and B and trypsin (Dauch et al., 1991b Checler, 1991) . This tight-binding constant confirms that phosphonamide analogues can efficiently mimic the transition state of the scissile peptide bond and has already led to their development as potent inhibitors of metalloproteinases (Kam et al., 1979; Galardy, 1980; Hanson etal., 1989; Thorsett etal., 1982 (Cicilini etal., 1988) .
Phosphodiepryl 03 blocked the hydrolysis of both substrates of endopeptidase 24.15 with K, values (5-7.5nM ) that were about 10-fold higher than those obtained for endopeptidase 24.16 (see Table 1 ). It was not unexpected that phosphodiepryl 03 blocks endopeptidase 24.15. The two enzymes are clearly distinct, since they display different sensitivities towards various inhibitors or agents such as CPP-Ala-Ala-Tyr-pAB or dithiothreitol (Checler et al., 1986; Orlowski et al., 1988; Barelli et al., 1991) , were not immunologically related (Barelli et al., 1991) and attacked distinct cleavage sites on neurotensin and other natural peptides (Checler et al., 1986; Chu & Orlowski, 1985; Orlowski & Michaud, 1989; Yoshikawa et al., 1988) . In spite of all these differences, it was noteworthy that Mcc-Pro-Leu-Gly-Pro-D-Lys-Dnp was cleaved by both peptidases at the same Leu-Gly peptide bond (Dauchet al., 1991a; (Ondetti et al., 1979; Llorens et al., 1980; Jacobsen & Bartlett, 1981; Mumford et al., 1982; Malfroy & Schwartz, 1985) .
In conclusion, we report here on the ability of a phosphonamide peptide inhibitor, phosphodiepryl 03, to potently block endopeptidase 24.16 activity. This is the first agent that displays an affinity for the enzyme in the subnanomolar range. Furthermore, this inhibitor exhibits a high affinity for endopeptidase 24.15, such as to make it the most potent inhibitor of endopeptidase 24.15 developed to date. Finally, phosphodiepryl 03 exerts a rather selective inhibitory profile, since a 1000-fold higher concentration than is the K, value for endopeptidase 24.16 does not affect other zinc metallopeptidases such as leucine aminopeptidase, carboxypeptidase A, angiotensin-converting enzyme and endopeptidase 24.11. It is our hope that the described phosphonamide will be the starting point of a strategy leading to more potent and selective agents capable of blocking only endopeptidase 24.16 or 24.15, in order to assess the contribution of these enzymes in the physiological inactivation of neurotensin and other natural peptides in the central nervous system and in the periphery.
